期刊
ADVANCED SYNTHESIS & CATALYSIS
卷 361, 期 11, 页码 2421-2432出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adsc.201900424
关键词
biocatalysis; enzyme catalysis; industrial chemistry; sustainable chemistry
资金
- European Community
- EFPIA companies [115360]
- Strategic Long Larger (sLoLa) Grant Rapid Evolution of Enzymes and Synthetic Micro-organisms for the Development of Industrial Biocatalysts
- BIOCATNET NIBB (BBSRC) [BB/L013649/1]
- BBSRC [BB/K00199X/1]
- BBSRC [BB/L013649/1] Funding Source: UKRI
Biocatalysis over the past few years has matured into an essential tool for modern, cost effective and sustainable pharmaceutical manufacturing. While some reaction classes are well established, and may even be the option of first intent, other more recently discovered enzyme classes are being rapidly developed both in academia and industry. Notwithstanding this, there are further promising enzymes that require further investment and investigation to allow their future industrial use. We here outline GSK's perspective on the current status of biocatalysis for pharmaceutical manufacturing and provide our views on areas of significant potential.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据